Literature DB >> 23164069

Enucleation in Iceland 1992-2004: study in a defined population.

Asbjorg Geirsdottir1, Bjarni A Agnarsson, Gudleif Helgadottir, Haraldur Sigurdsson.   

Abstract

PURPOSE: To determine the incidence rate as well as causative diagnoses and surgical indications of enucleation in Iceland during the years 1992-2004.
METHODS: A retrospective population-based incidence study involving the entire population of Iceland. Medical records of all patients who underwent enucleation in Iceland from January 1992 through December 2004 were reviewed. The annually updated Icelandic census was used as a denominator data.
RESULTS: Fifty-six eyes were enucleated during 1992-2004. No eviscerations were done, and the three exenterations performed were not included in the study. The mean annual age-adjusted incidence rate of enucleation in Iceland was 1.48 enucleations per 100 000 population in comparison with 2.66 enucleations per 100 000 for the time period 1964-1991. With advancing age, a significant increasing linear trend existed (p < 0.001). The median age at enucleation was 51 years (SD 22; mean 55 years; 16-91 years). The three most common surgical indications for enucleation were blind painful eye, suspected ocular malignancy and acute trauma. The most common causative diagnosis for enucleation was traumatic lesion (39%). The annual incidence was 2.00 enucleations per 100 000 for men and 0.95 for women. There were significantly more men in the traumatic lesion group (p < 0.001), but no gender predominance was found in the other groups of causative diagnoses (p = 0.8).
CONCLUSION: The overall mean annual incidence of enucleation in Iceland is continually decreasing, although the incidence of severe ocular trauma and ocular malignancy is fairly stable.
© 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Keywords:  Iceland; blind painful eye; census; enucleation; incidence; malignant melanoma; population-based; trauma

Mesh:

Year:  2012        PMID: 23164069     DOI: 10.1111/aos.12004

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

Review 1.  [Ocular prosthetics. Fitting, daily use and complications].

Authors:  K R Koch; W Trester; N Müller-Uri; M Trester; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

2.  Comparative Study of Retrobulbar Block versus Ketamine Infusion during Eye Enucleation/Evisceration (Randomized Controlled Trial).

Authors:  Hassan Mohamed Ali; Ahmed Mohamed Elbadawy
Journal:  Anesth Essays Res       Date:  2020-02-14

3.  Enucleation and evisceration: indications, complications and clinicopathological correlations.

Authors:  Ali Kord Valeshabad; Masood Naseripour; Rajab Asghari; Seyed Hamid Parhizgar; Seyed Ehsan Parhizgar; Mohammad Taghvaei; Shahin Miri
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

4.  Removal of the eye in a tertiary care center of China: a retrospective study on 573 cases in 20 years.

Authors:  Ying Zhang; Mao-Nian Zhang; Xin Wang; Xiao-Fei Chen
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

5.  Changing indications for enucleation and selected unusual pathologies.

Authors:  Caroline Thaung
Journal:  Saudi J Ophthalmol       Date:  2019-08-27

Review 6.  The Evolution of Orbital Implants and Current Breakthroughs in Material Design, Selection, Characterization, and Clinical Use.

Authors:  Xiao-Yi Chen; Xue Yang; Xing-Li Fan
Journal:  Front Bioeng Biotechnol       Date:  2022-02-17

7.  Indications for enucleation and evisceration in a tertiary eye hospital in Riyadh over a 10-year period.

Authors:  Saad A Al-Dahmash; Sawsan Saad Bakry; Nada H Almadhi; Lolwah M Alashgar
Journal:  Ann Saudi Med       Date:  2017 Jul-Aug       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.